Table 5.

Inhibition of the proinflammatory enzymes.

Analyte	LOX		HYAL
	IC50 (μg/mL)∗	IC50 (μg/U)∗∗	IC50 (μg/mL)∗	IC50 (μg/U)∗∗
MED	188.1 ± 6.8e	6.94	18.3 ± 0.7f	16.0
DEF	91.6 ± 3.6b	3.38	25.3 ± 0.9h	22.2
EAF	89.8 ± 4.3b	3.31	12.4 ± 0.5c	10.9
BF	96.3 ± 3.7b,c	3.55	4.1 ± 0.2a	3.62
WR	265.3 ± 7.2f	9.79	11.3 ± 0.5c	9.94
QU	58.3 ± 2.3a	2.15	15.6 ± 0.9d,e	13.7
RT	104.8 ± 4.1c	3.86	23.2 ± 1.6g	20.4
CHA	114.3 ± 5.2d	4.21	16.5 ± 0.7e	14.5
ECA	90.6 ± 3.1b	3.34	14.3 ± 0.7d	12.5
PB2	77.0 ± 1.8b	2.84	12.8 ± 0.6d	11.2
IND	63.0 ± 2.7a	2.32	8.5 ± 0.4b	7.46

Results are presented as means ± SD (n = 3) calculated per dry weight of the extract or standard. For extract codes, see Table 1. Different superscripts in each column indicate significant differences in the means at p < 0.05. ^∗,∗∗Inhibition concentration (amount of analyte needed for 50% inhibition of enzyme activity) expressed as follows: ^∗in μg of the dry extract or standard/mL of the enzyme solution; ^∗∗in μg of the extracts/enzyme unit (U).